tradingkey.logo

Rockwell Medical Inc

RMTI
0.849USD
-0.001-0.09%
收盘 12/19, 16:00美东报价延迟15分钟
33.46M总市值
亏损市盈率 TTM

Rockwell Medical Inc

0.849
-0.001-0.09%

关于 Rockwell Medical Inc 公司

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

Rockwell Medical Inc简介

公司代码RMTI
公司名称Rockwell Medical Inc
上市日期Jan 27, 1998
CEOStrobeck (Mark)
员工数量244
证券类型Ordinary Share
年结日Jan 27
公司地址30142 Wixom Road
城市WIXOM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编48393
电话18004493353
网址https://www.rockwellmed.com/
公司代码RMTI
上市日期Jan 27, 1998
CEOStrobeck (Mark)

Rockwell Medical Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-2.38%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
140.37K
-3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2.19%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+79.23%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
105.95K
-0.83%
Mr. Robert S. Radie
Mr. Robert S. Radie
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Heather R. Hunter
Ms. Heather R. Hunter
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Allen R. Nissenson, M.D.
Dr. Allen R. Nissenson, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-2.38%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
140.37K
-3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2.19%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+79.23%

收入明细

FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Concentrate Products
16.07M
0.00%
Drug Products
0.00
0.00%
地区USD
名称
营收
占比
United States
14.19M
0.00%
Rest of World
1.88M
0.00%
业务
地区
业务USD
名称
营收
占比
Concentrate Products
16.07M
0.00%
Drug Products
0.00
0.00%

股东统计

更新时间: 11月18日 周二
更新时间: 11月18日 周二
持股股东
股东类型
持股股东
持股股东
占比
Irrevocable Larson Family Investment Trust
9.03%
The Vanguard Group, Inc.
3.44%
Renaissance Technologies LLC
1.43%
Geode Capital Management, L.L.C.
0.82%
Strobeck (Mark)
0.72%
其他
84.57%
持股股东
持股股东
占比
Irrevocable Larson Family Investment Trust
9.03%
The Vanguard Group, Inc.
3.44%
Renaissance Technologies LLC
1.43%
Geode Capital Management, L.L.C.
0.82%
Strobeck (Mark)
0.72%
其他
84.57%
股东类型
持股股东
占比
Corporation
9.03%
Investment Advisor
4.95%
Individual Investor
4.20%
Hedge Fund
2.01%
Investment Advisor/Hedge Fund
1.47%
Research Firm
0.09%
Venture Capital
0.04%
其他
78.21%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
98
6.21M
18.04%
-1.88M
2025Q2
119
12.15M
35.56%
-1.45M
2025Q1
124
11.25M
32.97%
-1.96M
2024Q4
123
12.47M
38.59%
-1.21M
2024Q3
113
13.08M
41.13%
+2.79M
2024Q2
102
9.50M
31.23%
+460.06K
2024Q1
118
5.89M
19.90%
-1.12M
2023Q4
118
5.97M
23.48%
-688.25K
2023Q3
122
6.04M
24.13%
+2.56M
2023Q2
133
3.92M
24.44%
+947.21K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Irrevocable Larson Family Investment Trust
3.56M
10.33%
+87.50K
+2.52%
Apr 11, 2025
The Vanguard Group, Inc.
1.21M
3.5%
--
--
Jun 30, 2025
Renaissance Technologies LLC
541.75K
1.57%
+88.75K
+19.59%
Jun 30, 2025
Geode Capital Management, L.L.C.
320.67K
0.93%
-3.87K
-1.19%
Jun 30, 2025
Strobeck (Mark)
290.62K
0.84%
-6.93K
-2.33%
Jul 01, 2025
BlackRock Institutional Trust Company, N.A.
217.66K
0.63%
+1.98K
+0.92%
Jun 30, 2025
Ravich (Mark H)
151.10K
0.44%
+50.00K
+49.45%
May 20, 2025
Radie (Robert Samuel)
143.52K
0.42%
+50.00K
+53.46%
May 20, 2025
Timmins (Megan Carden)
142.68K
0.41%
+97.50K
+215.79%
May 20, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
占比0.01%
Dimensional US Core Equity 1 ETF
占比0%
DFA Dimensional US Sustainability Core 1 ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
公告日期
类型
比率
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1

常见问题

Rockwell Medical Inc的前五大股东是谁?

Rockwell Medical Inc 的前五大股东如下:
Irrevocable Larson Family Investment Trust持有股份:3.56M,占总股份比例:10.33%。
The Vanguard Group, Inc.持有股份:1.21M,占总股份比例:3.50%。
Renaissance Technologies LLC持有股份:541.75K,占总股份比例:1.57%。
Geode Capital Management, L.L.C.持有股份:320.67K,占总股份比例:0.93%。
Strobeck (Mark)持有股份:290.62K,占总股份比例:0.84%。

Rockwell Medical Inc的前三大股东类型是什么?

Rockwell Medical Inc 的前三大股东类型分别是:
Irrevocable Larson Family Investment Trust
The Vanguard Group, Inc.
Renaissance Technologies LLC

有多少机构持有Rockwell Medical Inc(RMTI)的股份?

截至2025Q3,共有98家机构持有Rockwell Medical Inc的股份,合计持有的股份价值约为6.21M,占公司总股份的18.04%。与2025Q2相比,机构持股有所增加,增幅为-17.52%。

哪个业务部门对Rockwell Medical Inc的收入贡献最大?

在FY2025Q2,Concentrate Products业务部门对Rockwell Medical Inc的收入贡献最大,创收16.07M,占总收入的--%。
KeyAI